Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis

Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis

Bibliographic Details
Main Authors:	Peterfy, Charles, Burmester, Gerd R, Bykerk, Vivian P, Combe, Bernard G, DiCarlo, Julie C, Furst, Daniel E, Huizinga, Tom W J, Wong, Dennis A, Conaghan, Philip G, Emery, Paul
Format:	Online
Language:	English
Published:	BMJ Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975847/

Similar Items

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
by: Emery, Paul, et al.
Published: (2015)

Abatacept in the treatment of rheumatoid arthritis
by: Vital, Edward M, et al.
Published: (2006)

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial
by: Conaghan, Philip G, et al.
Published: (2013)

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh, Chadi, et al.
Published: (2014)

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy
by: Conaghan, Philip G, et al.
Published: (2014)

Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI
by: Peterfy, Charles G, et al.
Published: (2012)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
by: Schiff, Michael
Published: (2013)

Etanercept in the treatment of rheumatoid arthritis
by: Haraoui, Boulos, et al.
Published: (2007)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
by: Lutt, Joseph R
Published: (2009)

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
by: Alten, Rieke, et al.
Published: (2016)

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
by: Schiff, Michael, et al.
Published: (2011)

Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
by: Truchetet, Marie-Elise, et al.
Published: (2016)

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
by: Kaine, Jeffrey, et al.
Published: (2011)

Patient‐Reported Outcomes From a Two‐Year Head‐to‐Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
by: Fleischmann, Roy, et al.
Published: (2016)

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis
by: Westhovens, Rene, et al.
Published: (2015)

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
by: Mathieu, Sylvain, et al.
Published: (2013)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
by: Lundquist, Lisa M, et al.
Published: (2012)

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
by: Harigai, Masayoshi, et al.
Published: (2016)

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
by: Schiff, Michael, et al.
Published: (2016)

Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study
by: Ursini, Francesco, et al.
Published: (2015)

Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept
by: Ospina, Fabio E., et al.
Published: (2014)

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
by: Deidda, Arianna, et al.
Published: (2014)

Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients
by: Imberti, Luisa, et al.
Published: (2015)

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
by: Kremer, Joel M, et al.
Published: (2011)

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
by: Alten, Rieke, et al.
Published: (2016)

MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
by: Peterfy, Charles, et al.
Published: (2016)

Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932)
by: Peterfy, Charles G, et al.
Published: (2013)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
by: Moretti, D, et al.
Published: (2013)

Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
by: Genovese, M C, et al.
Published: (2011)

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
by: C. Derambure, et al.
Published: (2017-05-01)

Update on the use of etanercept across a spectrum of rheumatoid disorders
by: Combe, Bernard
Published: (2008)

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
by: Nüßlein, Hubert G, et al.
Published: (2014)

Cells of the synovium in rheumatoid arthritis. Macrophages
by: Kinne, Raimund W, et al.
Published: (2007)

Biologicals in rheumatoid arthritis: current and future
by: Avci, Ali Berkant, et al.
Published: (2015)

Understanding emerging treatment paradigms in rheumatoid arthritis
by: Breedveld, Ferdinand C, et al.
Published: (2011)

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial
by: Conaghan, Philip G, et al.
Published: (2011)

Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arthritis Patients
by: MacIsaac, Kenzie D., et al.
Published: (2014)

Long term follow-up after sudden withdrawal from a multicentric study of abatacept in juvenile idiopathic arthritis – data from the Portuguese cohort
by: Gomes, S Melo, et al.
Published: (2011)

Investigating the Value of Abatacept in the Treatment of Rheumatoid Arthritis: A Systematic Review of Cost-Effectiveness Studies
by: Athanasakis, Kostas, et al.
Published: (2013)

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
by: Pieper, Jennifer, et al.
Published: (2013)